Logan Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $328K | Buy |
+3,621
| New | +$303K | 0.01% | 262 |
|
|
2026
Q1 | – | Sell |
-3,621
| Closed | -$299K | – | 354 |
|
|
2025
Q4 | $309K | Hold |
3,621
| – | – | 0.01% | 259 |
|
|
2025
Q3 | $282K | Hold |
3,621
| – | – | 0.01% | 258 |
|
|
2025
Q2 | $283K | Hold |
3,621
| – | – | 0.01% | 250 |
|
|
2025
Q1 | $262K | Hold |
3,621
| – | – | 0.01% | 269 |
|
|
2024
Q4 | $268K | Hold |
3,621
| – | – | 0.01% | 273 |
|
|
2024
Q3 | $239K | Hold |
3,621
| – | – | 0.01% | 279 |
|
|
2024
Q2 | $334K | Hold |
3,621
| – | – | 0.01% | 263 |
|
|
2024
Q1 | $346K | Hold |
3,621
| – | – | 0.01% | 265 |
|
|
2023
Q4 | $276K | Sell |
3,621
-18
| -0.5% | -$1.25K | 0.01% | 274 |
|
|
2023
Q3 | $252K | Hold |
3,639
| – | – | 0.01% | 272 |
|
|
2023
Q2 | $343K | Hold |
3,639
| – | – | 0.02% | 259 |
|
|
2023
Q1 | $301K | Hold |
3,639
| – | – | 0.01% | 273 |
|
|
2022
Q4 | $272K | Hold |
3,639
| – | – | 0.01% | 276 |
|
|
2022
Q3 | $301K | Hold |
3,639
| – | – | 0.02% | 260 |
|
|
2022
Q2 | $346K | Hold |
3,639
| – | – | 0.02% | 260 |
|
|
2022
Q1 | $428K | Sell |
3,639
-525
| -13% | -$58.9K | 0.02% | 255 |
|
|
2021
Q4 | $539K | Hold |
4,164
| – | – | 0.02% | 250 |
|
|
2021
Q3 | $471K | Hold |
4,164
| – | – | 0.02% | 258 |
|
|
2021
Q2 | $431K | Buy |
4,164
+15
| +0.4% | +$1.41K | 0.02% | 255 |
|
|
2021
Q1 | $347K | Buy |
4,149
+18
| +0.4% | +$1.52K | 0.02% | 257 |
|
|
2020
Q4 | $377K | Buy |
4,131
+510
| +14% | +$42.3K | 0.02% | 280 |
|
|
2020
Q3 | $289K | Sell |
3,621
-1,200
| -25% | -$93.6K | 0.02% | 339 |
|
|
2020
Q2 | $333K | Hold |
4,821
| – | – | 0.02% | 264 |
|
|
2020
Q1 | $303K | Sell |
4,821
-231
| -5% | -$16.7K | 0.02% | 282 |
|
|
2019
Q4 | $393K | Buy |
5,052
+21
| +0.4% | +$1.64K | 0.02% | 269 |
|
|
2019
Q3 | $369K | Hold |
5,031
| – | – | 0.02% | 268 |
|
|
2019
Q2 | $310K | Hold |
5,031
| – | – | 0.02% | 272 |
|
|
2019
Q1 | $321K | Hold |
5,031
| – | – | 0.02% | 270 |
|
|
2018
Q4 | $257K | Hold |
5,031
| – | – | 0.02% | 262 |
|
|
2018
Q3 | $292K | Buy |
5,031
+210
| +4% | +$10.3K | 0.02% | 265 |
|
|
2018
Q2 | $234K | Buy |
+4,821
| New | +$225K | 0.02% | 272 |
|
|
2013
Q3 | – | Sell |
-882,474
| Closed | -$15.2M | – | 265 |
|
|
2013
Q2 | $15.2M | Buy |
+882,474
| New | +$10.4M | 1.22% | 25 |
|
Other funds holding EW
Logan Capital Management's EW Position: Q2 2026 in Review
Logan Capital Management opened a new position in Edwards Lifesciences (EW) in Q2 2026: 3,621 shares worth $328K. The stake represents 0.01% of the portfolio and ranks #262 among its holdings. This is a return to the name: Logan Capital Management previously reported a position in EW as recently as Q4 2025.
Logan Capital Management first reported a position in EW in Q2 2013 and has held it in 33 quarters since. The position peaked at $15.2M in Q2 2013. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Logan Capital Management held 3,621 shares of Edwards Lifesciences worth $328K as of Q2 2026.
- Edwards Lifesciences was a new Logan Capital Management position in Q2 2026.
- Edwards Lifesciences made up 0.01% of Logan Capital Management's portfolio in Q2 2026, its #262 holding.
- Logan Capital Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 33 quarters since.
- Logan Capital Management's Edwards Lifesciences position peaked at $15.2M in Q2 2013.
- 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Logan Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.